Trial Profile
A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intramuscular and Intravenous Administration of Autologous ADMSCS for Treatment of Critical Limb Ischemia (CLI).
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adipose-derived autologous stem cell therapy-Kasiak Research (Primary) ; Adipose-derived autologous stem cell therapy-Kasiak Research (Primary) ; Stromal vascular fraction; Stromal vascular fraction
- Indications Chronic limb-threatening ischemia
- Focus Adverse reactions
- Sponsors Kasiak Research
- 30 Jul 2014 New trial record